Lead Trials with
Predictability, Not Panic
for Sponsors
StudyOrchestrator™ helps you translate protocol intent into real-world delivery—without adding friction for sites or waiting on lagging indicators.
You own the protocol — but execution happens elsewhere.
You design the trial. Sites deliver it. But without the right visibility and coordination, the gap between protocol and reality can cost months and millions.
Monitoring reports arrive too late, issues snowball, and sites struggle under the weight of amendments and admin work.
Only 13%
sponsors have real-time execution visibility
3+ Months
extending timelines due to protocol amendments
$600K–$8M
cost of each month delayed in lost revenue
How StudyOrchestrator™ Fits Your Site
We built StudyOrchestrator™ to work within your sites’ workflows—not add more to their plate—so adoption is easy, compliance is smoother, and you get the visibility you need.
Protocol-specific guardrails
reduce ambiguity and ensure visits run exactly as intended
Change-ready
adjust to amendments without introducing chaos or downtime
Real-time visibility
see coordination status and potential risks before they become costly problems
Early warning detection
drives actions to help mitigate when things don't go according to plan, stop of looking in the rearview mirror.
Zero added burden to sites
improves site efficiency and payment timelines, making it a win-win.
100% to you
customizable
No two protocols are the same — and StudyOrchestrator™ doesn’t force you into someone else’s mold.
​
Every workflow, guardrail, and notification can be configured to match your oversight requirements and trial design. From protocol-specific visit windows to amendment-ready workflows, you get a coordination hub that feels like it was built in-house — because in a way, it is.
​
This isn’t another rigid sponsor system. It’s orchestration that works for you.
Running a trial without real-time visibility is like driving while staring in the rearview mirror.
The difference you'll see
Stronger protocol compliance
Less disruption from protocol amendments
Lower dropout and missed milestones
Improves predictability across the study
Earlier intervention to migrate risks
Protected time-to-market and asset value
